Rockwell Medical targets $1M–$2M adjusted EBITDA and positive cash flow in 2026 as product mix diversifies (NASDAQ:RMTI)
Group 1 - The article does not provide any relevant content regarding company or industry insights [1]
Group 1 - The article does not provide any relevant content regarding company or industry insights [1]